Status:
COMPLETED
The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
Lead Sponsor:
Inje University
Collaborating Sponsors:
Sanofi
Conditions:
Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40-80 years
Phase:
PHASE4
Brief Summary
In type 2 diabetic patients, tight blood glucose control often requires both fasting and post-prandial glucose control separately. In the diabetic patients already on the insulin glargine treatment fo...
Eligibility Criteria
Inclusion
- Korean
- Type 2 diabetes mellitus
- No prior history of diabetic ketoacidosis
- HbA1c between 7.5-10.0%
Exclusion
- Type 1 diabetes mellitus
- Gestational diabetes mellitus
- Secondary diabetes mellitus
- Severe hyperglycemia with symptoms
- Severe chronic diabetic complications (PDR,s-Cr\>1.3mg/dL)
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT00437918
Start Date
January 1 2007
End Date
March 1 2008
Last Update
March 24 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Paik Diabetes Center, Pusan Paik Hospital, College of Medicine, Inje University
Busan, South Korea, 614-735
2
Endocrinology and Metabolism, Maryknoll General Hospital
Busan, South Korea